Search

everythinglearnresearchcommunity

for

Search:↓

Surgical removal of a scalp keratoacanthoma is effective and prevents recurrence, but hair may not regrow.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Activating Notch signaling can kill basal cell carcinoma cells.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

FDG PET/CT scans can change cancer treatment plans for dogs.

SCDSFs from zebrafish embryos are beneficial for treating cancer, regenerating tissues, and improving conditions like psoriasis and alopecia.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.